Small Business Innovation Research · Small Business Technology Transfer
Zenobia Therapeutics, Inc.: SBIR & STTR awards
6 awards worth $2.66M to 1 companies since 2009 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Zenobia Therapeutics, Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 1 | 0 | $250.0K |
| 2023 | 0 | 1 | $1.00M |
| 2019 | 1 | 0 | $225.0K |
| 2016 | 1 | 0 | $397.8K |
| 2010 | 1 | 0 | $456.3K |
| 2009 | 1 | 0 | $328.8K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
By agency
- National Science Foundation 2 awards · $1.23M
- Department of Health and Human Services 3 awards · $1.18M
- Department of Education 1 awards · $250.0K
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Sci-Quest: An Interactive Guided Hero's Journey through the Scientific Method to teach Core Scientific Concepts and Hands-on Skills to Underrepresented Populations in Science · topic 91990025R0003 | Zenobia Therapeutics, Inc. · California | Department of Education · Institute of Education Sciences | SBIR Phase I | $250.0K | 2025-09-12 |
| SBIR Phase II: A web-application that enables hands-on biotech laboratory education for students regardless of socioeconomic status · topic LC | Zenobia Therapeutics, Inc. · California | National Science Foundation | SBIR Phase II | $1.00M | 2023-01-15 |
| SBIR Phase I: XplorStem(TM): A smartphone/tablet application that enables hands-on biotech laboratory education for all students regardless of socioeconomic status · topic EA | Zenobia Therapeutics, Inc. · California | National Science Foundation | SBIR Phase I | $225.0K | 2019-07-01 |
| I Corp Program fro HOT ROXS An integrated platform for identifying activators of "non druggable" targets · topic 100 | Zenobia Therapeutics, Inc. · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $397.8K | 2016-06-01 |
| Discovery of inhibitors of the lipopolysaccharide synthesis pathway enzymes LpxA · topic NIAID | Zenobia Therapeutics, Inc. · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $456.3K | 2010 |
| Discovery of inhibitors of ALK for the treatment of cancer | Zenobia Therapeutics, Inc. · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $328.8K | 2009 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.